Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 15 , ISSUE 5 ( September-October, 2023 ) > List of Articles

Original Article

To Study the Average Possible Low Dose of Magnesium Sulfate to Control the Convulsions in Eclampsia in a Tertiary Care Hospital

Varsha Narayana Bhat, Shamrao Ramji Wakode, Kiran Ambatwar

Keywords : Birth weight, Cesarean, Comorbidities, Eclampsia, Maternal and fetal outcome, Preeclampsia

Citation Information : Bhat VN, Wakode SR, Ambatwar K. To Study the Average Possible Low Dose of Magnesium Sulfate to Control the Convulsions in Eclampsia in a Tertiary Care Hospital. J South Asian Feder Obs Gynae 2023; 15 (5):560-563.

DOI: 10.5005/jp-journals-10006-2302

License: CC BY-NC 4.0

Published Online: 31-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Objective: The aim of this study is to evaluate the efficacy of minimal effective dose of magnesium sulfate (MgSO4) for control of convulsions in eclampsia and also at reducing the MgSO4-related toxicity thus by reducing the dose of MgSO4 and also to analyze the maternal and perinatal outcomes among these patients. Design: The prospective observational study was carried out between January 2019 and January 2022 at Dr. Shankarrao Chavan Govt Medical College and Hospital, Nanded, Maharashtra. Setting: Tertiary care hospital, Nanded, Maharashtra. Materials and methods: Injection of MgSO4 14 gm loading dose was given at the admission in eclampsia cases, and further doses of MgSO4 were given with close monitoring of patients and a reduction in the number of doses of MgSO4 doses was done as per the patient's condition. If the patient gets the next episode of convulsion, immediately 2 gm IV MgSO4 drip was given. Results: In our study, out of 200 patients, 2.5% of them had received only a loading dose of MgSO4, whereas maximum (61.5%) of them had received 20–24 gm of MgSO4. During the observation period of 5–7 days post delivery, none of the patients had any complications like repeat convulsions, loss of consciousness, or intracranial hemorrhage, even after reducing the possible doses of MgSO4. The recurrence rate of convulsions is 7%. Total MgSO4 doses were administered (in grams) with a mean of 24.83 gm among the study population. There was no significant correlation between doses of MgSO4 received, and the number of convulsions reoccurred with p-value > 0.05. Conclusion: It appears that treatment of eclampsia cases should be individualized by considering the level of consciousness, laboratory parameters, induction delivery interval, convulsion to delivery interval, number of convulsions, and hence deciding further maintenance doses to be given or omitted. Due to the low toxicity profile, reduced monitoring, cost-effectiveness, and equally effective in comparison with the Pritchard regimen, the present regimen is recommended.

PDF Share
  1. Nobis PN, Hajong A. Eclampsia in India through the decades. J Obstet Gynaecol India 2016;66(Suppl1):172–176. DOI: 10.1007/s13224-015-0807-5.
  2. Pritchard JA, Cunningham FG, Pritchard SA. The Pakland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984;148(7):951–963. DOI: 10.5555/uri:pii:0002937884905386.
  3. Shamsuddin L, Nahar K, Nasrin B, et al. Use of parenteral MgSO4 in eclampsia and severe preeclampsia cases in rural set up of Bangladesh. Bangladesh Med Res Counc Bull 2005;31(2):75–82. PMID: 16967813.
  4. Pannu D, Das B, Hazari P, et al. Maternal and perinatal outcome in eclampsia and factors affecting the outcome: A study in North Indian population. Int J Reprod Contracept Obstet Gynecol 2014;3(2): 347–351.
  5. Gaddi S, Somegowda S. Maternal and perinatal outcome in eclampsia in a district hospital. J Obstet Gynecol India 2007;57:324–326.
  6. Shikha S, Nagrath A, Singh, DK. Comparison of low dose, single loading dose, and standard Pritchard regimen of magnesium sulfate in antepartum eclampsia. Anatol J Obstet Gynecol 2010;1:1–6.
  7. Bilano VL, Ota E Ganchimeg T, et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: A WHO secondary analysis. PLoS One 2014;9(3):e91198. DOI: 10.1371/journal.pone.0091198.
  8. Singh A, Shrivastava C. Changing trends in eclampsia and increasing cesarean delivery – An interesting retrospective study from a tertiary care hospital of Raipur. Int J Reprod Contracept Obstet Gynecol 2016;5(4):1031–1103. DOI: 10.18203/2320-1770.ijrcog20160853.
  9. Kuljit K, Shrivastav RD, Rahatgaonkar V, et al. Study of fetal and maternal outcome in eclampsia. Int J Recent Trends Sci Technol 2014:11(1):42–44. ISSN: 2277-2812.
  10. Sandip L, Chandra MS, Ranjan PS. Early decision of caesarean section in eclampsia to improve maternal and perinatal outcome. Indian J Med Res Pharm Sci 2014;1(7). ISSN: 2349 5340.
  11. Edgar NM, Albert K, Richard R, et al. Maternal and perinatal outcome among eclamptic patients admitted to Bugando Medical Centre, Mwanza, Tanzania. Afr J Reprod Health 2012;16(1):35–41. PMID: 22783666.
  12. Sibai BM. Magnesium sulphate is the ideal anticonvulsant in preeclampsia–eclampsia. Am J Obstet Gynecol 1990;162:1141–1145. DOI: 10.1016/0002-9378(90)90002-o.
  13. Suman S, Shivanjali M, Ajit P, et al. Low dose magnesium sulphate therapy for eclampsia and imminent pre-eclampsia: Regime tailored for Indian women. J Obstet Gynecol India 2003;53:540–546.
  14. Garg R, Agrawal N, Kumari SS, et al. Low-dose magnesium sulfate regime for eclampsia in India. J SAFOG 2017;9(1):5–8. DOI: 10.5005/jp-journals-10006-1447.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.